Events

33rd Medicinal Chemistry in Eastern England

Event
33rd Medicinal Chemistry in Eastern England

Dates
Thursday, 28th April 2022

Place
Fielder Centre, Hatfield

Important links
Twitter hashtag – #HatfieldMedChem22

Synopsis
Known colloquially as the “Hatfield MedChem” meeting, this a highly successful, long-standing, one-day meeting which runs annually. The scientific program will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics from the forefront of drug discovery of relevance to medicinal chemists.

Registration
Registration opening soon, please keep checking for updates.

Exhibition/Sponsorship Opportunities
Bookings opening soon, please keep checking for updates

Confirmed speakers
Martin Ambler (LifeArc)
The Development of PROTACs at LifeArc

Mark Charles (Cancer Research UK)
Discovery and optimisation of allosteric inhibitors of Glutaminase 1 (GLS1)

Laura Cleghorn (University of Dundee)
Discovery and first disclosure of DDU209 a potent and selective inhibitor of Lysyl tRNA synthetase for Tuberculosis

David Davies (Antabio)
Discovery of novel LasB inhibitors as an inhaled antivirulence therapy for the treatment of Pseudomonas aeruginosa infections in patients with chronic respiratory disease

Teresa de Haro (UCB)
Development and characterisation of 2-imino-hexahydropyrimidin-4-one derived Plasmepsin X inhibitors with in vivo anti-malarial activity

Samantha Hughes (AstraZeneca)
Next generation estrogen receptor degraders (SERDs): A decade of discovery at AstraZeneca

Nick Martin (Domainex)
Development of MAP4K4 Inhibitors for the Suppression of Cardiac Muscle Cell Death

Shane Rountree (Almac Group)
Discovery and development of first-in-class USP19 inhibitors for the treatment of metabolic and muscle-wasting diseases

Dr Jérémy Besnard – Capps Green Zomaya Award Winner talk

Steve Watson (Sosei Heptares)
The discovery of  novel  GPR52 agonists:  HTL0041178, a potential therapy for schizoaffective and related psychiatric disorders

 

Organising Committee
Nicole Hamblin, Charles River (Chair)
Adrian Hall, UCB (Treasurer)
David Hirst, MSD

Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail